NEFL and Alzheimer disease: In addition to classical markers for AD pathology, one of the more studied biomarkers in serum and CSF is the neurofilament light chain (NfL), which represents neuron-specific markers of axonal damage, despite lacking disease specificity and being detected in a wide range of NDDs.